Navigation Links
Certain Antidepressants Ease Fibromyalgia Symptoms
Date:1/13/2009

Tricyclic medications helped with pain, fatigue and depression, study shows

TUESDAY, Jan. 13 (HealthDay News) -- Antidepressants may help people living with the chronic pain of fibromyalgia experience fewer symptoms and improve their quality of life, new research shows.

The study, lead by Dr. Winfried Hauser, of Klinikum Saarbrucken in Germany, found that fibromyalgia patients had less pain, fatigue and depression while on certain antidepressants.

Tricyclic and tetracyclic antidepressants helped the most to reduce pain, fatigue and sleep disturbances, according to the report published in the Jan. 14 issue of the Journal of the American Medical Association. Serotonin and noradrenaline reuptake inhibitors helped with those three symptoms but to a much lesser extent, while selective serotonin reuptake inhibitors and monoamine oxidase inhibitors helped lessen pain some.

Fibromyalgia affects up to nearly 6 percent of people in North America and Europe, carrying with it high direct and indirect disease-related costs.

"Since evidence for a long-term effect of antidepressants in [fibromyalgia] is still lacking, their effects should be re-evaluated at regular intervals to determine whether benefits outweigh adverse effects," the authors wrote in a news release from the journal. "The identification of patient characteristics associated with positive and negative therapeutic outcomes are needed to better target antidepressant therapy for [fibromyalgia]."

More information

The National Fibromyalgia Association has more about fibromyalgia.



-- Kevin McKeever



SOURCE: JAMA, news release, Jan. 13, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Use of certain lipid measures not more effective in predicting coronary heart disease
2. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
3. MU researchers studying model to learn why certain cancers become resistant to drugs
4. New All-Natural Dietary Supplement Made from Muscadine Grape Skins Helps Inhibit Growth of Certain Cancers
5. Effectiveness of most PTSD therapies is uncertain
6. Value of Most Post-Traumatic Stress Treatments Uncertain
7. Certain Seizure Patients Need Emergency CT Scan
8. Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories
9. Certain Cholesterol Drugs Show Their Limits
10. ADHD Delays Growth of Certain Brain Areas
11. Stress hormone may hasten the progression of certain blood cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Certain Antidepressants Ease Fibromyalgia Symptoms 
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy ... adults, has kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), ... “Attachment Informed Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The adage ... Flex House, the next project in the company’s esteemed VISION House demonstration project series. ... use exactly the amount of resources they need to live affordably and abundantly without ...
(Date:4/21/2017)... Arvada, CO (PRWEB) , ... April 21, 2017 ... ... health and performance system, has partnered with O2X , an active lifestyle ... are focused on improving the health of firefighters, police offers, first responders, military ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... Joseph Health held the much anticipated Regional Primary Care Spring Symposium on April ... in the local medical community, offering physicians and healthcare providers an opportunity to ...
(Date:4/21/2017)... City, UT (PRWEB) , ... April 21, 2017 , ... ... solutions, recently partnered with Advanced Patient Care of Utah (APCUT) and has appointed Rex ... for the next chapter of growth for our agency and our ability to provide ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/18/2017)... Ohio , April 18, 2017  Cardinal Health ... Non-GAAP 1 fiscal 2017 earnings per share (EPS) ... and 2019.  This is in conjunction with this morning,s ... Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... from continuing operations will be at the bottom of ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: